US Stock MarketDetailed Quotes

PBLA Panbela Therapeutics

Watchlist
  • 0.440
  • -0.040-8.31%
15min DelayClose May 17 16:00 ET
2.14MMarket Cap0.01P/E (TTM)

Panbela Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
38.40%6.73M
-24.77%25.65M
35.96%7.04M
116.56%7.85M
-72.39%5.88M
21.38%4.86M
240.59%34.09M
56.48%5.18M
63.94%3.62M
856.24%21.29M
Selling and administrative expenses
-10.95%1.2M
-16.73%5.03M
-45.07%931K
-14.45%1.11M
30.60%1.64M
-24.72%1.35M
31.76%6.04M
33.36%1.7M
40.04%1.29M
1.37%1.26M
-General and administrative expense
-10.95%1.2M
-16.73%5.03M
-45.07%931K
-14.45%1.11M
30.60%1.64M
-24.72%1.35M
31.76%6.04M
33.36%1.7M
40.04%1.29M
1.37%1.26M
Research and development costs
57.41%5.52M
-26.51%20.61M
75.36%6.11M
189.35%6.74M
-78.86%4.23M
58.88%3.51M
417.22%28.05M
70.88%3.49M
81.10%2.33M
1,933.30%20.03M
Operating profit
-38.40%-6.73M
24.77%-25.65M
-35.96%-7.04M
-116.56%-7.85M
72.39%-5.88M
-21.38%-4.86M
-240.59%-34.09M
-56.48%-5.18M
-63.94%-3.62M
-856.24%-21.29M
Net non-operating interest income expense
26.74%-63K
29.20%-194K
64.41%-63K
72.84%-22K
-50.00%-21K
-4,200.00%-86K
-2,390.91%-274K
-5,800.00%-177K
-8,000.00%-81K
-250.00%-14K
Non-operating interest income
--0
778.57%123K
125.00%9K
716.67%49K
2,350.00%49K
1,500.00%16K
1,300.00%14K
--4K
500.00%6K
--2K
Non-operating interest expense
-38.24%63K
10.07%317K
-60.22%72K
-18.39%71K
337.50%70K
3,300.00%102K
2,300.00%288K
5,933.33%181K
4,250.00%87K
300.00%16K
Other net income (expense)
-180.84%-469K
157.48%392K
0.49%614K
102.39%18K
90.33%-82K
-153.70%-167K
-13.29%-682K
6,688.89%611K
-125.07%-754K
-472.97%-848K
Special income (charges)
----
--400K
--0
--400K
----
----
--0
--0
--0
----
-Gain on sale of property,plant,equipment
----
--400K
--0
--400K
----
----
--0
--0
--0
----
Other non- operating income (expenses)
-180.84%-469K
98.83%-8K
0.49%614K
49.34%-382K
90.33%-82K
-153.70%-167K
-13.29%-682K
6,688.89%611K
-125.07%-754K
-472.97%-848K
Income before tax
-41.95%-7.26M
27.39%-25.45M
-36.78%-6.49M
-76.09%-7.85M
73.00%-5.98M
-38.38%-5.11M
-229.94%-35.05M
-43.63%-4.75M
-75.10%-4.46M
-831.37%-22.15M
Income tax
-138K
-60.34%-186K
-58.33%-19K
66.07%-19K
-716.67%-147K
0
76.23%-116K
-105.15%-12K
86.14%-56K
90.63%-18K
Net income
-39.25%-7.12M
27.68%-25.26M
-36.73%-6.47M
-77.90%-7.83M
73.64%-5.83M
-39.47%-5.11M
-244.68%-34.93M
-33.83%-4.74M
-105.51%-4.4M
-912.35%-22.13M
Net income continuous Operations
-39.25%-7.12M
27.68%-25.26M
-36.73%-6.47M
-77.90%-7.83M
73.64%-5.83M
-39.47%-5.11M
-244.68%-34.93M
-33.83%-4.74M
-105.51%-4.4M
-912.35%-22.13M
Minority interest income
Net income attributable to the parent company
-39.25%-7.12M
27.68%-25.26M
-36.73%-6.47M
-77.90%-7.83M
73.64%-5.83M
-39.47%-5.11M
-244.68%-34.93M
-33.83%-4.74M
-105.51%-4.4M
-912.35%-22.13M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-39.25%-7.12M
27.68%-25.26M
-36.73%-6.47M
-77.90%-7.83M
73.64%-5.83M
-39.47%-5.11M
-244.68%-34.93M
-33.83%-4.74M
-105.51%-4.4M
-912.35%-22.13M
Basic earnings per share
99.42%-2.28
98.42%-316.52
99.60%-13.4868
98.94%-53.8
99.38%-159
94.00%-392.76
-10.36%-19.97K
46.06%-3.41K
-32.66%-5.08K
-391.55%-25.58K
Diluted earnings per share
99.42%-2.28
98.42%-316.52
99.60%-13.4868
98.94%-53.8
99.38%-159
94.00%-392.76
-10.36%-19.97K
46.06%-3.41K
-32.66%-5.08K
-391.55%-25.58K
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 38.40%6.73M-24.77%25.65M35.96%7.04M116.56%7.85M-72.39%5.88M21.38%4.86M240.59%34.09M56.48%5.18M63.94%3.62M856.24%21.29M
Selling and administrative expenses -10.95%1.2M-16.73%5.03M-45.07%931K-14.45%1.11M30.60%1.64M-24.72%1.35M31.76%6.04M33.36%1.7M40.04%1.29M1.37%1.26M
-General and administrative expense -10.95%1.2M-16.73%5.03M-45.07%931K-14.45%1.11M30.60%1.64M-24.72%1.35M31.76%6.04M33.36%1.7M40.04%1.29M1.37%1.26M
Research and development costs 57.41%5.52M-26.51%20.61M75.36%6.11M189.35%6.74M-78.86%4.23M58.88%3.51M417.22%28.05M70.88%3.49M81.10%2.33M1,933.30%20.03M
Operating profit -38.40%-6.73M24.77%-25.65M-35.96%-7.04M-116.56%-7.85M72.39%-5.88M-21.38%-4.86M-240.59%-34.09M-56.48%-5.18M-63.94%-3.62M-856.24%-21.29M
Net non-operating interest income expense 26.74%-63K29.20%-194K64.41%-63K72.84%-22K-50.00%-21K-4,200.00%-86K-2,390.91%-274K-5,800.00%-177K-8,000.00%-81K-250.00%-14K
Non-operating interest income --0778.57%123K125.00%9K716.67%49K2,350.00%49K1,500.00%16K1,300.00%14K--4K500.00%6K--2K
Non-operating interest expense -38.24%63K10.07%317K-60.22%72K-18.39%71K337.50%70K3,300.00%102K2,300.00%288K5,933.33%181K4,250.00%87K300.00%16K
Other net income (expense) -180.84%-469K157.48%392K0.49%614K102.39%18K90.33%-82K-153.70%-167K-13.29%-682K6,688.89%611K-125.07%-754K-472.97%-848K
Special income (charges) ------400K--0--400K----------0--0--0----
-Gain on sale of property,plant,equipment ------400K--0--400K----------0--0--0----
Other non- operating income (expenses) -180.84%-469K98.83%-8K0.49%614K49.34%-382K90.33%-82K-153.70%-167K-13.29%-682K6,688.89%611K-125.07%-754K-472.97%-848K
Income before tax -41.95%-7.26M27.39%-25.45M-36.78%-6.49M-76.09%-7.85M73.00%-5.98M-38.38%-5.11M-229.94%-35.05M-43.63%-4.75M-75.10%-4.46M-831.37%-22.15M
Income tax -138K-60.34%-186K-58.33%-19K66.07%-19K-716.67%-147K076.23%-116K-105.15%-12K86.14%-56K90.63%-18K
Net income -39.25%-7.12M27.68%-25.26M-36.73%-6.47M-77.90%-7.83M73.64%-5.83M-39.47%-5.11M-244.68%-34.93M-33.83%-4.74M-105.51%-4.4M-912.35%-22.13M
Net income continuous Operations -39.25%-7.12M27.68%-25.26M-36.73%-6.47M-77.90%-7.83M73.64%-5.83M-39.47%-5.11M-244.68%-34.93M-33.83%-4.74M-105.51%-4.4M-912.35%-22.13M
Minority interest income
Net income attributable to the parent company -39.25%-7.12M27.68%-25.26M-36.73%-6.47M-77.90%-7.83M73.64%-5.83M-39.47%-5.11M-244.68%-34.93M-33.83%-4.74M-105.51%-4.4M-912.35%-22.13M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -39.25%-7.12M27.68%-25.26M-36.73%-6.47M-77.90%-7.83M73.64%-5.83M-39.47%-5.11M-244.68%-34.93M-33.83%-4.74M-105.51%-4.4M-912.35%-22.13M
Basic earnings per share 99.42%-2.2898.42%-316.5299.60%-13.486898.94%-53.899.38%-15994.00%-392.76-10.36%-19.97K46.06%-3.41K-32.66%-5.08K-391.55%-25.58K
Diluted earnings per share 99.42%-2.2898.42%-316.5299.60%-13.486898.94%-53.899.38%-15994.00%-392.76-10.36%-19.97K46.06%-3.41K-32.66%-5.08K-391.55%-25.58K
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg